TITLE

Review: Short-acting insulin analogues reduce glycosylated hemoglobin more than regular human insulin but only in adults with type 1 diabetes

PUB. DATE
May 2005
SOURCE
ACP Journal Club;May/Jun2005, Vol. 142 Issue 3, p63
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article cites a medical study which states that short-acting insulin analogues reduce glycosylated hemoglobin more than regular human insulin but only in adults with type 1 diabetes. Randomized controlled trials (RCTs) ≥ 4 weeks in duration compared short-acting insulin analogues with regular human insulin in patients with type 1, type 2, or gestational diabetes. Methodological quality was assessed using the criteria in the Cochrane Handbook and the criteria of Schulz and Jadad. It was found that in adults with type 2 diabetes, children, and women with gestational diabetes, insulin analogues and regular human insulin do not differ in effect.
ACCESSION #
17116522

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics